{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T15:11:00Z","timestamp":1766848260610},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,12]]},"DOI":"10.7759\/cureus.25870","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T15:18:01Z","timestamp":1655047081000},"source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Cirrhosis on Outcomes of Patients Admitted With Diabetic Ketoacidosis: A Nationwide Study"],"prefix":"10.7759","author":[{"given":"Mahmoud M","family":"Mansour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adham E","family":"Obeidat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Darweesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratib","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Kuwada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos T","family":"Pyrsopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi AE","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009, 32:1335-43. 10.2337\/dc09-9032","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002451","article-title":"Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus","volume":"9","author":"Ooi E","year":"2021","unstructured":"Ooi E, Nash K, Rengarajan L, et al.. Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2021, 9:1-8. 10.1136\/bmjdrc-2021-002451","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0284","article-title":"Diabetic ketoacidosis: update on management","volume":"19","author":"Evans K","year":"2019","unstructured":"Evans K. Diabetic ketoacidosis: update on management. Clin Med (Lond). 2019, 19:396-8. 10.7861\/clinmed.2019-0284","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2021.1978741","article-title":"Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018","volume":"35","author":"Kichloo A","year":"2022","unstructured":"Kichloo A, El-Amir Z, Wani F, Shaka H. Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proc (Bayl Univ Med Cent). 2022, 35:1-5. 10.1080\/08998280.2021.1978741","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan D","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008, 371:838-51. 10.1016\/S0140-6736(08)60383-9","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","unstructured":"GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020, 5:245-66. 10.1016\/S2468-1253(19)30349-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00183","article-title":"Diagnosis and clinical implications of diabetes in liver cirrhosis: a focus on the oral glucose tolerance test","volume":"1","author":"Nishida T","year":"2017","unstructured":"Nishida T. Diagnosis and clinical implications of diabetes in liver cirrhosis: a focus on the oral glucose tolerance test. J Endocr Soc. 2017, 1:886-96. 10.1210\/js.2017-00183","journal-title":"J Endocr Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean D","year":"2009","unstructured":"Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009, 15:280-8. 10.3748\/wjg.15.280","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_79_18","article-title":"Hepatogenous diabetes: an underestimated problem of liver cirrhosis","volume":"22","author":"Kumar R","year":"2018","unstructured":"Kumar R. Hepatogenous diabetes: an underestimated problem of liver cirrhosis. Indian J Endocrinol Metab. 2018, 22:552-9. 10.4103\/ijem.IJEM_79_18","journal-title":"Indian J Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33650","article-title":"Diabetes increases the risk of acute hepatic failure","volume":"122","author":"El-Serag HB","year":"2002","unstructured":"El-Serag HB, Everhart JE. Diabetes increases the risk of acute hepatic failure. Gastroenterology. 2002, 122:1822-8. 10.1053\/gast.2002.33650","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag HB","year":"2004","unstructured":"El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004, 126:460-8. 10.1053\/j.gastro.2003.10.065","journal-title":"Gastroenterology"},{"key":"ref12","unstructured":"Overview of the National (Nationwide) Inpatient Sample (NIS). (2021). Accessed. May 6, 2022: http:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201120","article-title":"Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study","volume":"13","author":"Lapointe-Shaw L","year":"2018","unstructured":"Lapointe-Shaw L, Georgie F, Carlone D, et al.. Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study. PLoS One. 2018, 13:e0201120. 10.1371\/journal.pone.0201120","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13115","article-title":"Diabetes mellitus in patients with cirrhosis: clinical implications and management","volume":"36","author":"Elkrief L","year":"2016","unstructured":"Elkrief L, Rautou PE, Sarin S, Valla D, Paradis V, Moreau R. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int. 2016, 36:936-48. 10.1111\/liv.13115","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.06.095","article-title":"Diabetes and hepatocellular carcinoma: a pathophysiological link and pharmacological management","volume":"106","author":"Singh MK","year":"2018","unstructured":"Singh MK, Das BK, Choudhary S, Gupta D, Patil UK. Diabetes and hepatocellular carcinoma: a pathophysiological link and pharmacological management. Biomed Pharmacother. 2018, 106:991-1002. 10.1016\/j.biopha.2018.06.095","journal-title":"Biomed Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0456-3","article-title":"Insulin receptor endocytosis in the pathophysiology of insulin resistance","volume":"52","author":"Hall C","year":"2020","unstructured":"Hall C, Yu H, Choi E. Insulin receptor endocytosis in the pathophysiology of insulin resistance. Exp Mol Med. 2020, 52:911-20. 10.1038\/s12276-020-0456-3","journal-title":"Exp Mol Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.588519","article-title":"Advanced glycation end products as a predictor of diabetes mellitus in chronic hepatitis C-related cirrhosis","volume":"7","author":"Abdel-Razik A","year":"2020","unstructured":"Abdel-Razik A, Mousa N, Zakaria S, et al.. Advanced glycation end products as a predictor of diabetes mellitus in chronic hepatitis C-related cirrhosis. Front Med (Lausanne). 2020, 7:588519. 10.3389\/fmed.2020.588519","journal-title":"Front Med (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0096-z","article-title":"The role of hypoxia-inducible factors in metabolic diseases","volume":"15","author":"Gonzalez FJ","year":"2018","unstructured":"Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol. 2018, 15:21-32. 10.1038\/s41574-018-0096-z","journal-title":"Nat Rev Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.08.011","article-title":"Contribution of \u03b2-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease","volume":"63","author":"Grancini V","year":"2015","unstructured":"Grancini V, Trombetta M, Lunati ME, et al.. Contribution of \u03b2-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease. J Hepatol. 2015, 63:1484-90. 10.1016\/j.jhep.2015.08.011","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2020-0024","article-title":"Pulmonary complications in patients with liver cirrhosis","volume":"8","author":"Benz F","year":"2020","unstructured":"Benz F, Mohr R, Tacke F, Roderburg C. Pulmonary complications in patients with liver cirrhosis. J Transl Int Med. 2020, 8:150-8. 10.2478\/jtim-2020-0024","journal-title":"J Transl Int Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(03)01207-1","article-title":"Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis","volume":"125","author":"Schenk P","year":"2003","unstructured":"Schenk P, Sch\u00f6niger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, M\u00fcller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003, 125:1042-52. 10.1016\/s0016-5085(03)01207-1","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99268-the-impact-of-cirrhosis-on-outcomes-of-patients-admitted-with-diabetic-ketoacidosis-a-nationwide-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:50Z","timestamp":1707507890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99268-the-impact-of-cirrhosis-on-outcomes-of-patients-admitted-with-diabetic-ketoacidosis-a-nationwide-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,12]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.25870","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,12]]}}}